Jakura, also known as tofacitinib, in its 5mg dosage, represents a significant breakthrough in the management of rheumatoid arthritis (RA). This administered medication, a specific Janus kinase (JAK) inhibitor, works by suppressing the signaling pathways that contribute to inflammation and joint